OKC Thunder Wire on MSN
Everything Thunder said about Nikola Topic's NBA debut, cancer treatment
Everything Oklahoma City Thunder said about Nikola Topic's NBA debut, cancer treatment.
Researchers have identified a biological mechanism that helps explain why some lung and ovarian cancers become resistant to chemotherapy, offering insight into why cancers recur. The study, published ...
A team of researchers from the Andalusian Centre for Molecular Biology and Regenerative Medicine (CABIMER) and the University of Seville, in collaboration with the Virgen Macarena University Hospital, ...
Nikola Topic's health became a major story after a cancer diagnosis. Here’s what happened and how he returned.
After a year and a half of waiting to make an NBA debut, what’s a few more seconds? Oklahoma City Thunder guard Nikola Topic sidled his way to the scorer’s tabl ...
Blue Shield of California determined the veteran first responder is ineligible for immunotherapy, citing FDA and Medicare guidelines.
Brebeuf girls' basketball coach Erin Miller did not know if she could make it through season after cancer diagnosis. She ...
The FDA has approved Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the first and only subcutaneous, chemo-free ...
Survivorship is a relational shift for the whole family, not a return to pre-cancer life. Fear of recurrence affects the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results